Mark A. Socinski, MD
Advertisement
Mark Socinski, MD, is a medical oncologist and the executive medical director of the AdventHealth Cancer Institute in Orlando, Florida.
Articles by Mark A. Socinski, MD
Advertisement
Latest Updated Articles
Dr. Socinski on the Evolving Paradigm of Targeted Therapy in Lung CancerPublished: May 18th 2021 | Updated:
ROS1 Alterations in Advanced NSCLCPublished: October 25th 2021 | Updated:
Clinical Management of ROS1+ Advanced NSCLCPublished: October 25th 2021 | Updated:
Dr. Socinski on Recent Setbacks in Immunotherapy Combinations in NSCLCPublished: February 7th 2017 | Updated:
Dr. Socinski on Milestone of Immunotherapy in Lung CancerPublished: March 6th 2017 | Updated:
Dr. Socinski on Improvements to Immunotherapy for Lung CancerPublished: April 26th 2017 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
2
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma
5